Accordingly, pharmacological inhibition of MET prevented the tumor-promoting activity of IKKβ-deficient fibroblasts, confirming the significance of HGF/MET signaling for the crosstalk between cancer cells and tumor-promoting fibroblasts. The gene discussed is HGF; the disease is cancer.